Citizens Financial Group Inc. RI Sells 126 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Citizens Financial Group Inc. RI cut its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.4% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 30,105 shares of the company’s stock after selling 126 shares during the quarter. Citizens Financial Group Inc. RI’s holdings in HCA Healthcare were worth $12,236,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the business. Bangor Savings Bank boosted its holdings in shares of HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the 2nd quarter valued at about $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare during the 2nd quarter valued at approximately $28,000. GPS Wealth Strategies Group LLC boosted its position in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. bought a new position in HCA Healthcare in the 2nd quarter valued at approximately $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Stock Down 0.6 %

HCA Healthcare stock opened at $333.00 on Thursday. The business has a fifty day moving average of $381.99 and a two-hundred day moving average of $358.12. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. The firm has a market cap of $84.35 billion, a P/E ratio of 14.95, a P/E/G ratio of 1.29 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $245.84 and a twelve month high of $417.14.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 dividend on an annualized basis and a yield of 0.79%. HCA Healthcare’s dividend payout ratio is currently 11.85%.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,155 shares of company stock worth $5,608,990. Insiders own 1.60% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have weighed in on HCA. Leerink Partners boosted their target price on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Truist Financial increased their price target on HCA Healthcare from $390.00 to $430.00 and gave the company a “buy” rating in a research note on Monday, August 19th. Royal Bank of Canada increased their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Morgan Stanley initiated coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective for the company. Finally, KeyCorp cut their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research note on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $385.00.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.